These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 19368899)

  • 1. Is serum brain-derived neurotrophic factor a biomarker for cognitive enhancement in schizophrenia?
    Vinogradov S; Fisher M; Holland C; Shelly W; Wolkowitz O; Mellon SH
    Biol Psychiatry; 2009 Sep; 66(6):549-53. PubMed ID: 19368899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cognitive cost of anticholinergic burden: decreased response to cognitive training in schizophrenia.
    Vinogradov S; Fisher M; Warm H; Holland C; Kirshner MA; Pollock BG
    Am J Psychiatry; 2009 Sep; 166(9):1055-62. PubMed ID: 19570929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroplasticity-based auditory training via laptop computer improves cognition in young individuals with recent onset schizophrenia.
    Fisher M; Loewy R; Carter C; Lee A; Ragland JD; Niendam T; Schlosser D; Pham L; Miskovich T; Vinogradov S
    Schizophr Bull; 2015 Jan; 41(1):250-8. PubMed ID: 24444862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations of serum brain-derived neurotrophic factor with cognitive impairments and negative symptoms in schizophrenia.
    Niitsu T; Shirayama Y; Matsuzawa D; Hasegawa T; Kanahara N; Hashimoto T; Shiraishi T; Shiina A; Fukami G; Fujisaki M; Watanabe H; Nakazato M; Asano M; Kimura S; Hashimoto K; Iyo M
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Dec; 35(8):1836-40. PubMed ID: 21930178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low serum truncated-BDNF isoform correlates with higher cognitive impairment in schizophrenia.
    Carlino D; Leone E; Di Cola F; Baj G; Marin R; Dinelli G; Tongiorgi E; De Vanna M
    J Psychiatr Res; 2011 Feb; 45(2):273-9. PubMed ID: 20630543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroscience-informed Auditory Training in Schizophrenia: A Final Report of the Effects on Cognition and Serum Brain-Derived Neurotrophic Factor.
    Fisher M; Mellon SH; Wolkowitz O; Vinogradov S
    Schizophr Res Cogn; 2016 Mar; 3():1-7. PubMed ID: 26705516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combining computerized social cognitive training with neuroplasticity-based auditory training in schizophrenia.
    Sacks S; Fisher M; Garrett C; Alexander P; Holland C; Rose D; Hooker C; Vinogradov S
    Clin Schizophr Relat Psychoses; 2013; 7(2):78-86A. PubMed ID: 23367504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low BDNF is associated with cognitive impairment in chronic patients with schizophrenia.
    Zhang XY; Liang J; Chen DC; Xiu MH; Yang FD; Kosten TA; Kosten TR
    Psychopharmacology (Berl); 2012 Jul; 222(2):277-84. PubMed ID: 22274000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain-derived neurotrophic factor as a biomarker for cognitive recovery in acute schizophrenia: 12-week results from a prospective longitudinal study.
    Zhang Y; Fang X; Fan W; Tang W; Cai J; Song L; Zhang C
    Psychopharmacology (Berl); 2018 Apr; 235(4):1191-1198. PubMed ID: 29392373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computerized cognitive training restores neural activity within the reality monitoring network in schizophrenia.
    Subramaniam K; Luks TL; Fisher M; Simpson GV; Nagarajan S; Vinogradov S
    Neuron; 2012 Feb; 73(4):842-53. PubMed ID: 22365555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of peripheral levels of chemokines, BDNF and oxidative markers on cognition in individuals with schizophrenia.
    Asevedo E; Gadelha A; Noto C; Mansur RB; Zugman A; Belangero SI; Berberian AA; Scarpato BS; Leclerc E; Teixeira AL; Gama CS; Bressan RA; Brietzke E
    J Psychiatr Res; 2013 Oct; 47(10):1376-82. PubMed ID: 23806580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive function and serum levels of brain-derived neurotrophic factor in patients with bipolar disorder.
    Dias VV; Brissos S; Frey BN; Andreazza AC; Cardoso C; Kapczinski F
    Bipolar Disord; 2009 Sep; 11(6):663-71. PubMed ID: 19689509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BDNF as a marker of response to cognitive remediation in patients with schizophrenia: A randomized and controlled trial.
    Penadés R; López-Vílchez I; Catalán R; Arias B; González-Rodríguez A; García-Rizo C; Masana G; Ruíz V; Mezquida G; Bernardo M
    Schizophr Res; 2018 Jul; 197():458-464. PubMed ID: 29274733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum BDNF and GDNF in Chinese male patients with deficit schizophrenia and their relationships with neurocognitive dysfunction.
    Tang X; Zhou C; Gao J; Duan W; Yu M; Xiao W; Zhang X; Dong H; Wang X; Zhang X
    BMC Psychiatry; 2019 Aug; 19(1):254. PubMed ID: 31420036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum brain-derived neurotrophic factor levels associate with cognitive improvement in patients with schizophrenia treated with electroacupuncture.
    Sun ZL; Liu J; Guo W; Jiang T; Ma C; Li WB; Tang YL; Ling SH
    Psychiatry Res; 2016 Oct; 244():370-5. PubMed ID: 27525826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of macular xanthophyll supplementation on brain-derived neurotrophic factor, pro-inflammatory cytokines, and cognitive performance.
    Stringham NT; Holmes PV; Stringham JM
    Physiol Behav; 2019 Nov; 211():112650. PubMed ID: 31425700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased levels of serum brain-derived neurotrophic factor in drug-naïve first-episode schizophrenia: relationship to clinical phenotypes.
    Chen DC; Wang J; Wang B; Yang SC; Zhang CX; Zheng YL; Li YL; Wang N; Yang KB; Xiu MH; Kosten TR; Zhang XY
    Psychopharmacology (Berl); 2009 Dec; 207(3):375-80. PubMed ID: 19787338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Impact of Aerobic Exercise on Brain-Derived Neurotrophic Factor and Neurocognition in Individuals With Schizophrenia: A Single-Blind, Randomized Clinical Trial.
    Kimhy D; Vakhrusheva J; Bartels MN; Armstrong HF; Ballon JS; Khan S; Chang RW; Hansen MC; Ayanruoh L; Lister A; Castrén E; Smith EE; Sloan RP
    Schizophr Bull; 2015 Jul; 41(4):859-68. PubMed ID: 25805886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroplasticity-based cognitive training in schizophrenia: an interim report on the effects 6 months later.
    Fisher M; Holland C; Subramaniam K; Vinogradov S
    Schizophr Bull; 2010 Jul; 36(4):869-79. PubMed ID: 19269924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationships between serum brain-derived neurotrophic factor, plasma catecholamine metabolites, cytokines, cognitive function and clinical symptoms in Japanese patients with chronic schizophrenia treated with atypical antipsychotic monotherapy.
    Hori H; Yoshimura R; Katsuki A; Atake K; Igata R; Konishi Y; Nakamura J
    World J Biol Psychiatry; 2017 Aug; 18(5):401-408. PubMed ID: 27409727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.